← Leaderboards
Shiyong Wu
University Of Michigan At Ann Arbor
$5,015,525
Attributed
$6,003,315
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $948.9K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,003,315 · 4
By mechanism
R01$3,821,346 · 2
R42$1,975,581 · 1
R56$206,388 · 1
Top collaborators
- Craig S Nunemaker3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Sewon Kang$4,187,120
- Jack E Dixon$15,595,348
- Daniel Dimaio$34,640,869
- Alan P Boyle$9,857,541
- Jiayuh Lin$5,012,132
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisCell DeathMediatingSignal TransductionCellsCessation Of LifePreventLeadPreventionNitric OxideNitric Oxide SynthasePeroxonitriteRegulationPathway InteractionsMalignant NeoplasmsCell InjuryInnovationAffectMolecularApoptoticDna DamageIrradiationPhosphorylationPlay
Grant awards (21)
A dual-acting small molecule for the treatment of type 1 diabetes$625,501
R42 · FY2025 · DK · contact PI
A dual-acting small molecule for the treatment of type 1 diabetes$740,897
R42 · FY2024 · DK · contact PI
A dual-acting small molecule for the treatment of type 1 diabetes$609,183
R42 · FY2023 · DK · contact PI
Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses$339,750
R01 · FY2023 · ES · contact PI
Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses$339,750
R01 · FY2022 · ES · contact PI
Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses$339,750
R01 · FY2021 · ES · contact PI
Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses$339,750
R01 · FY2020 · ES · contact PI
Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses$339,750
R01 · FY2019 · ES · contact PI
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis$254,434
R01 · FY2012 · CA · contact PI
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis$202,809
R01 · FY2011 · CA · contact PI
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis$7,741
R01 · FY2011 · CA · contact PI
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis$209,081
R01 · FY2010 · CA · contact PI
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis$4,335
R01 · FY2010 · CA · contact PI
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis$209,081
R01 · FY2009 · CA · contact PI
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis$209,081
R01 · FY2008 · CA · contact PI
UV-induced and NOS-mediated Zn elevation, translation regulatin and apoptosis.$206,388
R56 · FY2007 · CA · contact PI
UV INDUCED AND PERK MEDIATED SIGNALING PATHWAYS$195,750
R01 · FY2004 · CA
UV INDUCED AND PERK MEDIATED SIGNALING PATHWAYS$195,750
R01 · FY2003 · CA
UV INDUCED AND PERK MEDIATED SIGNALING PATHWAYS$203,850
R01 · FY2002 · CA
UV INDUCED AND PERK MEDIATED SIGNALING PATHWAYS$203,850
R01 · FY2001 · CA
UV INDUCED AND PERK MEDIATED SIGNALING PATHWAYS$226,834
R01 · FY2000 · CA